Firstly, the reported prescribing error rate may be considered together with the recent study on DWLS dispensing errors [16] as preliminary evidence of the potential of GLP-1 RA-supported DWLSs to deliver safe obesity care. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.